121 related articles for article (PubMed ID: 18236001)
1. Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-epsilon4 carriers.
Aidaralieva NJ; Kamino K; Kimura R; Yamamoto M; Morihara T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Kida T; Okuda JI; Uema T; Yamagata H; Miki T; Akatsu H; Kosaka K; Takeda M
J Hum Genet; 2008; 53(4):296-302. PubMed ID: 18236001
[TBL] [Abstract][Full Text] [Related]
2. Decrease of dynamin 2 levels in late-onset Alzheimer's disease alters Abeta metabolism.
Kamagata E; Kudo T; Kimura R; Tanimukai H; Morihara T; Sadik MG; Kamino K; Takeda M
Biochem Biophys Res Commun; 2009 Feb; 379(3):691-5. PubMed ID: 19126407
[TBL] [Abstract][Full Text] [Related]
3. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
4. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
5. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
[TBL] [Abstract][Full Text] [Related]
6. DNMBP is genetically associated with Alzheimer dementia in the Belgian population.
Bettens K; Brouwers N; Engelborghs S; De Pooter T; De Deyn PP; Sleegers K; Van Broeckhoven C
Neurobiol Aging; 2009 Dec; 30(12):2000-9. PubMed ID: 18359537
[TBL] [Abstract][Full Text] [Related]
7. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
[TBL] [Abstract][Full Text] [Related]
8. [Genetic risk factor of Alzheimer's disease].
Kuwano R
Rinsho Shinkeigaku; 2007 Nov; 47(11):908-11. PubMed ID: 18210832
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
11. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.
Haasl RJ; Ahmadi MR; Meethal SV; Gleason CE; Johnson SC; Asthana S; Bowen RL; Atwood CS
BMC Med Genet; 2008 Apr; 9():37. PubMed ID: 18439297
[TBL] [Abstract][Full Text] [Related]
12. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
Jiang S; Yang W; Qiu Y; Chen HZ;
Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
[TBL] [Abstract][Full Text] [Related]
14. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variability in a large Czech family with a dynamin 2-associated Charcot-Marie-Tooth neuropathy.
Haberlová J; Mazanec R; Ridzoň P; Baránková L; Nürnberg G; Nürnberg P; Sticht H; Huehne K; Seeman P; Rautenstrauss B
J Neurogenet; 2011 Dec; 25(4):182-8. PubMed ID: 22091729
[TBL] [Abstract][Full Text] [Related]
16. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele.
Bernardini S; Bellincampi L; Ballerini S; Federici G; Iori R; Trequattrini A; Ciappi F; Baldinetti F; Bossù P; Caltagirone C; Spalletta G
Clin Chem; 2005 Jun; 51(6):944-51. PubMed ID: 15805147
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
19. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
